Journal article · 2024 · Open access
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey
The Lancet Microbe, 5(10), 100920 · Published 16 August 2024 · DOI 10.1016/s2666-5247(24)00160-5
In brief
“Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey” is a 2024 journal article by Jonathan J. Juliano and 26 co-authors, published in The Lancet Microbe. OpenAlex counts 54 citations as of 19 November 2026, which puts it in the top 6% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at The Lancet Microbe.
- Citations
- 54
- Most cited in
- 2026 (32)
- Field-weighted impact
- 14.59
- References
- 33
- Authors
- 27
Abstract
BACKGROUND: The emergence of the artemisinin partial resistance (ART-R) mutation in the Plasmodium falciparum kelch13 gene (k13), Arg561His, in Rwanda and the regional presence of polymorphisms affecting sulfadoxine-pyrimethamine have raised concern in neighbouring Tanzania. The goal of this study was to assess the status of antimalarial resistance in Tanzania, with a focus on the border with Rwanda, to understand the distribution of the Arg561His mutation, partner drug resistance, and resistance to chemoprevention drugs. METHODS: In this cross-sectional survey, capillary dried blood spots were collected from malaria positive asymptomatic individuals in the community and symptomatic individuals in health facilities aged 6 months and older, in 13 regions of mainland Tanzania from Jan 31 to June 26, 2021. Exclusion criteria included residence of the areas other than the target sites, presenting to the health facility for care and treatment of conditions other than malaria, and not providing informed consent. Samples were assessed for antimalarial resistance polymorphisms and genetic relatedness using molecular inversion probes targeting P falciparum and short-read whole-genome sequencing. The primary outcome was the prevalence of molecular markers of antimalarial resistance at the region level, as well as at the district level in Kagera, a region in the northwest of the country at the border with Rwanda. FINDINGS: 6855 (88·1%) of 7782 capillary dried blood spot samples collected were successfully genotyped. The overall prevalence of k13 Arg561His in Kagera was 7·7% (90% CI 6·0-9·4; 50 of 649), with the highest prevalence in the districts near the Rwandan border (22·8% [31 of 136] in Karagwe, 14·4% [17 of 118]) in Kyerwa, and 1·4% [two of 144] in Ngara). k13 Arg561His was uncommon in the other regions. Haplotype analysis suggested that some of these parasites are related to isolates collected in Rwanda in 2015, supporting regional spread of Arg561His. However, a novel k13 Arg561His haplotype was observed, potentially indicating a second origin in the region. Other validated k13 resistance polymorphisms (one Arg622Ile and two Ala675Val isolates) were also identified. A region of prevalent dihydrofolate reductase Ile164Leu mutation, associated with sulfadoxine-pyrimethamine resistance, was also identified in Kagera (15·2% [12·6-17·8%]; 80 of 526). The mutant crt Lys76Thr mutation, associated with chloroquine and amodiaquine resistance, was uncommon, occurring only in 75 of 2861 genotyped isolates, whereases the wild-type mdr1 Asn86Tyr allele, associated with reduced sensitivity to lumefantrine, was found in 99·7% (3819 of 3830) of samples countrywide. INTERPRETATION: These findings show that the k13 Arg561His mutation is common in northwest Tanzania and that multiple emergences of ART-R, similar as to what was seen in southeast Asia…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Juliano, J. J., Giesbrecht, D., Simkin, A., Fola, A. A., Lyimo, B. M., Pereus, D., Bakari, C., Madebe, R. A., Seth, M. D., Mandara, C. I., Popkin-Hall, Z. R., Moshi, R., Mbwambo, R. B., Niaré, K., MacInnis, B. L., Francis, F. T., Mbwambo, D., Garimo, I. A., Chacky, F., . . . Ishengoma, D. S. (2024). Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey. The Lancet Microbe, 5(10), 100920. https://doi.org/10.1016/s2666-5247(24)00160-5
MLA 9
Juliano, Jonathan J., et al. “Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.” The Lancet Microbe, vol. 5, no. 10, 2024, p. 100920. https://doi.org/10.1016/s2666-5247(24)00160-5.
Chicago
Juliano, Jonathan J., David Giesbrecht, Alfred Simkin, Abebe Alemu Fola, Beatus Modest Lyimo, Dativa Pereus, Catherine Bakari, et al. 2024. “Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.” The Lancet Microbe 5 (10): 100920. https://doi.org/10.1016/s2666-5247(24)00160-5.
Harvard
Juliano, J. J. et al. (2024) ‘Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey’, The Lancet Microbe, 5(10), p. 100920. doi:10.1016/s2666-5247(24)00160-5.
IEEE
J. J. Juliano et al., “Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey,” The Lancet Microbe, vol. 5, no. 10, p. 100920, 2024, doi: 10.1016/s2666-5247(24)00160-5.
BibTeX
@article{juliano2024prevalence,
title = {{Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey}},
author = {Juliano, Jonathan J. and Giesbrecht, David and Simkin, Alfred and Fola, Abebe Alemu and Lyimo, Beatus Modest and Pereus, Dativa and Bakari, Catherine and Madebe, Rashid A. and Seth, Misago D. and Mandara, Celine I. and Popkin-Hall, Zachary R. and Moshi, Ramadhan and Mbwambo, Ruth B. and Niaré, Karamoko and MacInnis, Bronwyn L. and Francis, Filbert T. and Mbwambo, Daniel and Garimo, Issa Ally and Chacky, Frank and Aaron, Sijenunu and Lusasi, Abdallah and Molteni, Fabrizio and Njau, Ritha and Nhiga, Samwel L. and Mohamed, Ally and Bailey, Jeffrey A. and Ishengoma, Deus S.},
journal = {The Lancet Microbe},
year = {2024},
volume = {5},
number = {10},
pages = {100920},
doi = {10.1016/s2666-5247(24)00160-5},
url = {https://doi.org/10.1016/s2666-5247(24)00160-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 3 | |
| 2025 | 19 | |
| 2026 | 32 |
Its field-weighted citation impact is 14.59: it has been cited 14.59 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- sulfadoxine-pyrimethamine resistance
- Plasmodium falciparum
- antimalarial drug resistance
- partner drug resistance
- haplotype analysis
- Kagera
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Juliano, J. J., Giesbrecht, D., Simkin, A., Fola, A. A., Lyimo, B. M., Pereus, D., Bakari, C., Madebe, R. A., Seth, M. D., Mandara, C. I., Popkin-Hall, Z. R., Moshi, R., Mbwambo, R. B., Niaré, K., MacInnis, B. L., Francis, F. T., Mbwambo, D., Garimo, I. A., Chacky, F., . . . Ishengoma, D. S. (2024). Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey. The Lancet Microbe, 5(10), 100920. https://doi.org/10.1016/s2666-5247(24)00160-5
How many times has this paper been cited?
54 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Lancet Microbe: sign in and open the full text from this page.
Who wrote this paper?
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, Abebe Alemu Fola, Beatus Modest Lyimo, Dativa Pereus, Catherine Bakari, Rashid A. Madebe, Misago D. Seth, Celine I. Mandara, Zachary R. Popkin-Hall, Ramadhan Moshi and 15 more.
What is the DOI of this paper?
10.1016/s2666-5247(24)00160-5, permanently at https://doi.org/10.1016/s2666-5247(24)00160-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.